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Introduction
A robot can be defined as, “a powered, computer-controlled 
manipulator with artificial sensing that can be programmed to move 
and position tools to carry out tasks” [1]. Basic robotics has been used 
since the 1950s at the National Aeronautics and Space Agency (NASA) 
with simple, robotic arm technology. Robotic arm use expanded into 
industrial use by companies such as General Motors Co. (Unimate) 
in the 1960s. By the 1980s, advances in microelectronics, computer 
technology and charge-coupled devices in digital imaging, video 
electronics and display technology set the stage for robotic innovation. 
As the first entrant to the field of robotic surgery, the United States’ 
Defense Advanced Research Projects Agency (DARPA) developed 
much of the technology behind telerobotic surgery in conjunction with 
NASA and the Stanford Research Institute. Using telepresence, the 
sensation of being in one place when you are actually in another, robots 
were seen as a feasible strategy for remotely operating on battlefield 
wounds [1,2]. 
In 1983, basic medical use of robots began with robotic arm 
assistance with orthopedic surgery. Brain biopsy guidance was also 
aided with robotic technology in the 1980s. The first prostate surgery 
to utilize robotic assistance was conducted in 1988. By the 1990s, 
robots were being used to hold cameras and various manufacturers 
were experimenting with voice control. Cyberknife (Accuray, Inc, 
Sunnyvale, CA) was used for stereotactic brain biopsy in 1994, and in 
1998, first- generation precursors to the modern robot platform, the 
Zeus Robotic Surgical System (Computer Motion Inc), and the da 
Vinci Surgical Systems (Intuitive Surgical, Inc., Sunnyvale, CA) were 
employed for gynecologic reanastamosis of fallopian tubes and cardiac 
bypass surgery, respectively. 
In the first year of the new millennium, the Food & Drug 
Administration (FDA) granted the da Vinci system approval for use in 
urologic surgery. That same year, the first robot-assisted laparoscopic 
Radical Prostatectomy (RAP) was performed. In 2003, Intuitive Surgical, 
Inc. purchased Computer Motion, effectively creating a monopoly for 
Intuitive Surgical, Inc. in the robotic surgery marketplace. 
Da Vinci Surgical Systems’ robot was approved for gynecologic 
surgery in 2005 [3]. By 2008, over 80,000 robotic surgeries were 
performed worldwide at roughly 400 centers [1]. Surgical training has 
adapted accordingly; greater than 1,200 gynecologic surgeons were 
trained in use of robot-assisted surgery in 2010 [3,4]. By 2011, more 
than 1,600 systems were installed and over 1.8 million procedures were 
being performed in a number of disciplines with the da Vinci robot [2]. 
Annual growth of the da Vinci system has been estimated between 27 
and 35% [2,5] and as of the most recent report in 2013, greater than 
14,000 systems are in use throughout the United States [3]. 
Literature Review 
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Abstract
Robotic surgery was first conceived by the United States military in the 1980s.  It rapidly developed in both 
complexity and utility and, in the early 21st century, modern robotic surgery for gynecologic and urologic surgery 
gained approval in the United States.  Today, an ever-increasing number and variety of surgical procedures enlist 
robotic-assistance.
Numerous anesthetic considerations for robotic surgery exist.  A few of the most important aspects of conducting 
a safe anesthetic include: investigating the patient’s co-morbid conditions, realizing the risks associated with the 
robotic equipment, and positioning the patient with care.  
This manuscript reviews the current literature on robotic-assisted surgery for gynecologic and urologic procedures 
with emphasis on history, marketplace, type, variety, and expansion of surgery in these fields.  The review focuses 
on practical considerations for the anesthesiologist caring for patients undergoing robotic surgery.  Preoperative, 
intraoperative and postoperative issues are explored in detail.  
The rapid expansion of robotic surgery worldwide requires thoughtful consideration of the technique’s 
weaknesses and associated risks.  This review provides a roadmap to adequately prepare anesthesiologists for 
care of gynecologic and urologic patients undergoing robot-assisted surgery.
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was employed to adequately review anesthetic considerations during 
robot-assisted gynecologic and urologic surgery.
Keywords that were input into the search engines included, 
“robotic surgery, ” “gynecologic,” “urologic,” “anesthesia” concerns, 
perioperative “management,” “complications,” and, “outcomes.” 
Search queries were then reviewed by title and abstract for relevance, 
with preference afforded to more recent manuscripts. 
Da Vinci Surgical Systems 
The da Vinci Surgical Systems robot consists of three parts: 1. 
control console; 2. tower; and 3. robot. The control console provides 
an ergonomic-design for the operator to comfortably sit and remotely 
manipulate the robot. It has binocular, high-definition, 3- dimensional 
optics that improves the surgical view over 2-dimensional imagery. 
The viewer is equipped with an infrared sensor that is able to detect 
the presence of an operator. When the surgeon is not engaged in 
the viewer, the sensor prevents the robotic arms from movement 
as an advanced safety feature that minimizes the risk of unwanted 
robotic arm movement [1,3,4,6]. The camera allows for adjustment 
of magnification, or scaling of the surgical field, and the console 
automatically adjusts robotic arm motion to eliminate operator tremor, 
thereby improving fine motor control. Manual controls are anatomic, 
allowing for 7-degrees of movement at the tip with 360-degree range 
of motion and 90-degrees of instrument articulation control attached 
to the robotic arms. The meticulous surgical dissection that can be 
achieved with articulating instruments nearly matches the manual 
dexterity of open surgery. The movement of instruments is intuitive, 
as opposed to the counteractive adaptation required to maneuver 
laparoscopic equipment [7]. Arm 1 and 2 are the right and left-hand 
controls, arm 3 is the camera, and arm 4 is typically used as a retractor. 
A foot pedal serves to activate electrocautery, ultrasound, focal point 
adjustments, instrument disengagement, and alternation of arms 
controlled by the manual controls [1]. All of these advances lead to the 
opportunity for greater surgical autonomy and decreased fatigue for 
the operator [3]. 
The tower houses the da Vinci video equipment that records and 
displays images of the surgical field in 2-dimensions for the rest of the 
surgical team to view and appropriately assist in the management of the 
patient. The robot, the third component of the da Vinci system, has 4 
arms and is positioned adjacent to the patient with the arms that lock 
into place above the surgical field. An assistant is required to exchange 
disposable instruments that attach to the robotic arms, to load sutures, 
and to fire staples when necessary [1,7]. 
The benefits of robotic surgery are potentially extensive, although 
long-term data in its use remains elusive due to the relatively recent 
advent of the technology. Several retrospective analyses have reported 
robotic surgery to be feasible and effective [8-10]. Surgical incisions 
are small and instrumentation is minimally invasive [1,11]. Surgical 
bleeding is reported to be quite low [3,10,12] as is the incidence 
of venous gas embolism [13]. Postoperative complications such as 
wound infections are reported to be minimal [10,14], narcotic usage is 
reported to be less [12,15], and postanesthesia care unit (PACU) stays 
are reported to be brief. Overall length of hospitalization is likewise 
shorter in duration, on average [1,3,4,15]. For oncologic surgery, initial 
data indicates better margin negative rates, and improved functional 
outcomes, including earlier return to activities of daily living [16]. 
Disadvantages to robotic surgery include the increased time 
required to operate, to position the patient, and to dock the robot, 
contributing to longer total operative times. This extension of surgical 
time is particularly pronounced with surgical teams who are training to 
use the robot, corresponding to the initial phase of practice known as 
“the learning curve.” It is estimated that operating room staff proficiency 
is achieved after 25 cases, but that surgical skills continue toimprove 
until 150–250 cases or beyond [17-19]. For example: surgeons need to 
adjust to the visual and tactile design, to develop muscle memory, and 
to discover preferences and limitations; nurses need to learn how to 
transport, set-up, calibrate, drape, and position the robot for surgery 
[1]. Prolonged operative time is compounded by the increased risk for 
morbidity during the learning curve [20]. Organized credentialing of 
providers, including attestations, case list submissions, and proctored 
case performance are only recently being considered by training 
programs, hospitals and other entities keen to ensure quality during 
the learning process [18]. 
Beyond the learning curve, there remain challenges to robotic 
surgery. Once the procedure has begun, there is no easy way to 
reposition the patient should that become necessary. Despite the 
intuitive controls, robotic surgery is still not able to exactly replicate 
the haptic sensation that an operator gets when they are directly or 
indirectly touching tissue with their hands or laparoscopic instruments 
[6,21]. Additionally, the equipment is bulky, accounting for a significant 
footprint in the operating theater [1]. This invariably decreases access 
to the patient, decreases the maneuverability of the surgical care team 
when called upon to circulate, and increases the risk of robotic arm 
collision with assistant, anesthesia workstation, or patient [1,4]. 
Long- term, prospective data validating robotic-assisted surgery’s 
utility and safety is still lacking. In the absence of long-term data, there 
is extensive marketing of the product by its sole provider that likely 
biases purchase decisions and patient demand [11]. Patients may be 
prone to misconstrue the term, “minimally invasive” to mean minor 
surgery, and consequently be at risk for falsely elevated expectations 
for recovery [11]. Further, a lack of competition typically leads to 
diminished responsiveness of a firm with respect to quality and 
pricing. Machine malfunction is a concern, particularly as costly units 
begin to age. Additionally, hospitals looking to purchase a robot can 
expect an upfront cost of 1.4-2.2 million dollars, $100,000-$150,000 
for annual maintenance costs, and $2,000 per instrument, which are 
fabricated with a 10-use limit [2,7]. Robot purchase costs, amortized 
over the lifespan of the machine, combined with annual maintenance 
costs account for roughly 70% of the additional costs of performing 
robotic surgery [5,17]. Discounting depreciation costs of the robot, the 
high cost of maintenance and consumables often make it the costlier 
surgical option [21]. 
Robot Surgery in Gynecology 
The da Vinci Surgical System received FDA approval for gynecologic 
use in 2005. The first Robot-Assisted Radical Hysterectomy (RRH) 
was performed in 2006 [3]. By 2009, more Robotic-assisted surgical 
procedures were performed for gynecologic indications than for all 
other specialties combined [22]. 
worldwide. Radical hysterectomy is the preferred option for patients 
with localized disease. Since the first reported RRH, many studies have 
documented feasibility, safety and efficacy of the procedure, including 
less blood loss, fewer complications, and briefer hospitalizations [3]; 
however, to date, no prospective studies have been reported. Early stage 
disease has been most extensively reported in retrospective reviews 
or cases series. Robotics has also been considered in fertility-sparing 
Cervical cancer is the second most common cancer among women 
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operations for early disease. Locally advanced or recurrent disease is 
still considered experimental for surgery with robotic assistance. Pelvic 
exenteration surgery with robot assistance has only been reported in 
case reports. 
The most common malignancy of the female reproductive organs 
is endometrial cancer. It is the leading indication for robotic surgery 
in gynecology following a number of favorable retrospective reviews 
and case series [3]. One study noted that robotic surgery reduces 
complications such as wound dehiscence, infection, ureteral injury, 
and renal failure [4]. Consensus opinion in the literature is that robotic 
surgery with hysterectomy and lymphadenectomy is preferable to open 
procedures and equivocal to laparoscopy [3]. In addition, retrospective 
data supports robot use for staging for endometrial cancer and suggests 
that perhaps robot surgery is superior to laparoscopy for morbidly 
obese patients [23,24]. 
Literature on robotic surgery for ovarian cancer is very limited, 
although it is being conducted at select centers for early stage disease 
[4]. This is due to the comprehensive staging required for this type 
of cancer as well as concerns for port-site metastases, cyst rupture 
and peritoneal seeding [4,25]. Salpingo-oophorectomies, pelvic mass 
resections and omentectomies are also being conducted for various 
indications with robotic assistance [26]. 
Robot Surgery in Urology 
Young performed the first radical prostate surgery in 1904 via the 
perineum. In 1947, Miller performed the first retropubic surgery. Then 
Walsh improved on the technique with nerve sparing surgery in 1982 
[19,27]. As mentioned above, RAP was performed in 2000 following 
the introduction of the da Vinci robot. 
Prostate cancer is the second leading cause of cancer death in men 
[19]. It affects older men, typically with several co-morbid conditions. 
Radical prostatectomy is the best option for long- term cancer control 
in patients with localized, or organ-confined disease [28]. By 2010, 
robot usage in prostate cancer surgery had become so pervasive that 
one study assessed robotic prostatectomy as a new gold standard [11]. 
It cited improved pain, decreased length of stay, smaller incisions 
and improved functional outcomes with comparable cancer-free 
survival. Perioperative and delayed complications that have occurred 
include the same complications seen with open surgery, such as: 
bleeding, lymphocele, stricture, contracture, incisional hernia, rectal 
injury, incontinence, impotence and inadequate margins [27,29,30]. 
Longitudinal studies to support the potential advantages of robotic 
prostatectomy weighed against the significant costs are still few in 
number. 
Bladder cancer was first treated with open radical cyctectomy in 
1949. Despite a reduction in mortality, complication rates remain 
significant [31]. Robotic surgery has recently been adapted to manage 
muscle invasive and high-risk non-invasive bladder cancer (superficial 
recurrent or chemotherapy resistant) with the hopes of decreasing 
patient morbidity with the procedure. Draining options include 
conduit diversion into small bowel and neobladder formation from 
bowel. Surgeons have been slow to incorporate robot into radical 
cystectomy due to concerns over the ability to adequately dissect lymph 
nodes, the feasibility of intracorporeal diversions, and the overall costs. 
Long term data is lacking for robotic cystectomy outcomes; however, 
more than 1,000 cases have been reportedly performed by a consortium 
of institutions [31].
Renal cancer is predominantly renal cell carcinoma. It typically 
presents in the 4th to 7th decade and, while radical nephrectomy used 
to be the gold standard for localized disease, Partial Nephrectomy 
(PN) is now indicated for T1 small renal masses [17,32]. By sparing 
nephrons, PN achieves similar cancer-free survival outcomes to radical 
nephrectomy, but decreases long-term morbidit [17]. McDougall 
introduced laparoscopic partial nephrectomy in 1993; then in 2004, 
Gettman reported the first robotic partial nephrectomy (RPN) [33]. 
Surgeons are using novel techniques to eliminate ischemia during 
robot-assisted, deep tumor resection with some success [32]. 
Obstruction of the ureteropelvic junction requires a pyeloplasty 
operation. Endoscopic and laparoscopic approaches have taken the 
place of open procedures over the past 20 years for most patients; 
nevertheless, the laparoscopic approach is technically demanding 
[21]. Robotic Pyeloplasty (RP) offers an alternative, potentially easier 
platform for intracorporeal suturing [21]. Newer techniques that 
incorporate a single-site with modified da Vinci instrumentation may 
improve further upon the surgical learning curve, but must be weighed 
against increased costs [34]. 
Testicular germ cell tumors present earlier than the other urologic 
malignancies, typically in the 3rd or 4th decade of life. Over 75% are 
localized (stage I) at diagnosis. Stage I seminoma is highly sensitive to 
radiotherapy. Stage I Nonseminomatous germ cell tumor is usually 
confirmed with Retroperitoneal Lymph Node Dissection (RPLND). 
Chemotherapy is useful in stage II or III disease. Robotic surgery to 
perform orchiectomy and RPLND has been reported [2]. Surgeons have 
also begun to use robots to assist with a host of benign renal conditions 
such as: pyelolithotomy, simple prostatectomy, diverticulectomy, 
spermatic cord denervation, simple cystectomy, sacrocolpopexy, 
urolithiasis, fistula repair, ureto-ureterostomy, ureterolysis, vasectomy 
reversal, vericocelectomy, and live-donor nephrectomy [2]. 
Perioperative Concerns 
The perioperative management of patients undergoing robotic-
assisted gynecologic or urologic surgery involves numerous unique 
considerations for the anesthesia provider. 
A systematic review of the patient’s history and physical 
examination is warranted prior to robotic surgery. Age, medications, 
allergies, surgical and anesthetic history should be noted. Baseline vital 
signs should be obtained and a thorough airway examination should 
be conducted. 
Obesity: Patient height, and weight should be carefully considered 
as obesity (BMI >30) may be accompanied by physiologic changes such 
as obstructive sleep apnea and restrictive pulmonary disease, difficult 
intubation, delayed gastric emptying, difficult vascular access or co-
morbid conditions such as cardiovascular disease or diabetes mellitus 
[35,36]. Obese patients may be at increased risk for conversion to open 
or aborted procedures [37,38]; consequently, serious deliberations 
should precede robotic surgery in obese patients, particularly as BMI 
approaches 40. 
Cardiac risk: Cardiovascular risk should be assessed, taking into 
account the patient’s symptoms, medications, studies, and exercise 
tolerance in addition to a consideration for the surgical risk, typically 
moderate for gynecologic or urologic robotic surgery. Current American 
Heart Association/ American College of Cardiology (AHA/ACC) 
guidelines should be followed when determining whether a patient 
has been optimized for surgery [39]. Beta-blocker medication should 
Preoperative assessment
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be continued perioperatively. Heart failure is likely to be exacerbated 
by the positioning required for robotic surgery [1]. Furthermore, 
attention should be paid to patients presenting with cardiac stents; the 
risk of surgical bleeding with anticoagulation therapy must be weighed 
against the possibility of intraoperative stent thrombosis and the 
challenge of management during robotic surgery [40]. 
Neurologic and ocular risk: Caution must also be exercised in 
proceeding to robotic surgery in patients with a known increase in 
intracranial pressure, as the patient’s positioning for robotic surgery 
will exacerbate the pressure. For shunted patients, shunt patency 
confirmation is mandatory preoperatively. Intraocular pressures 
will likely be elevated due to patient positioning for robotic surgery. 
One study reported elevations of intraocular pressures, on average, 
of 13mmHg in patients without preexisting eye pathology [41]. 
Dangerous pressures that risk retinal detachment, periorbital edema 
or neuropathy are possible in prolonged surgeries or in patients with 
pre-existing ocular pathology. 
Pulmonary and renal risk: Patients with pulmonary disease 
may not tolerate the physiologic changes associated with patient 
positioning. Accordingly, patients should be screened for a history 
of smoking in addition to symptoms of lung dysfunction. Similarly, 
renal insufficiency will likely be exacerbated by robotic surgery due to 
mechanical obstruction, patient positioning and fluid restrictions, and 
so care must be taken to optimize renal function preoperatively [42]. 
Gastrointestinal risk: Assessment should also include a discussion 
of gastrointestinal laxatives or enemas requested in preparation for the 
robotic surgery in order to decompress the bowel and minimize the risk 
of fecal contamination should bowel injury occur [19]. Combined with 
fasting, hypovolemia is a considerable risk that may affect intravenous 
catheter placement and fluid management decisions. 
Cancer risk: A unique consideration of 10-40% of renal cell 
carcinomas is the presence of paraneoplastic syndromes. If a patient 
has a paraneoplastic syndrome, the tumor may secrete ectopic 
hormones such as erythropoietin, renin, insulin or glucose that must 
be considered during surgery [33]. 
Cancer patients may have been previously treated with radiation 
therapy. Surgical resection could be considerably more difficult due 
to the fibrosis or bleeding resulting from previous radiotherapy. 
Chemotherapy can result in a number of systemic complications that 
affect intraoperative planning. Patients may have significant weight 
loss, anemia, nausea, and a predisposition to clot formation resulting 
in electrolyte abnormalities, hypothermia risk, decreased protein, 
malnutrition and embolism. Anesthetic planning should account for 
decreased protein binding and volume of distribution for medications; 
these changes may significantly alter pharmacokinetics. Additionally, 
a history of exposure to agents such as doxorubicin (cardiomyopathy) 
and bleomycin (pulmonary fibrosis) necessitates further preoperative 
testing [33]. 
At a minimum, preoperative studies for robotic cancer surgery 
should include electrocardiogram, chest radiograph, and blood work, 
notably: blood counts, coagulation status, renal function, and basic 
electrolytes. The patient’s blood should be typed and screened for 
unusual antigens. Fasting blood glucose should be noted before surgery 
for diabetic patients. Reflux, infection and deep vein thrombosis 
prophylaxis should be considered with non-particulate antacid, 
antibiotics (within 1 hour of surgical incision), subcutaneous heparin 
and sequential compression devices respectively. After completing the 
preoperative assessment, an American Society of Anesthesiologists 
(ASA) Physical Status score should be assigned, keeping in mind that 
a score of four or greater may be associated with increased risk for 
complications with robotic surgery [38]. 
Intra operative management
Intraoperative considerations for robotic gynecologic and urologic 
surgery will be considered in this section. While robotic surgery may 
appear similar to laparoscopic surgery, and therefore deserving of 
similar attention, many laparoscopic concerns are greatly exaggerated 
in robotic procedures and several unique features are present as well. 
Space limitations: As the complexity of equipment required for 
surgery continues to grow, the physical space required to accommodate 
the larger footprint for equipment such as robotic chassis and control 
stations is greater. In spite of new requirements, many facilities are 
space-limited, with older operating theaters that were not designed 
with robotics in mind [1]. With robot-related equipment crowding 
operating rooms, the movement of personnel may be compromised, 
and visualization of key aspects of patient care such as intravenous 
insertion points or endotracheal tube positioning may be obscured 
[7,26]. 
Monitoring and intravenous access: For most gynecologic and 
urologic surgery with a robot, standard ASA monitoring is sufficient 
[43]. If the patient’s medical condition warrants, if the procedure is 
technically difficult, or if the surgical team is still novice with respect 
to the learning curve, additional monitoring should be considered to 
account for patient co-morbidities, the risk of intraoperative bleeding, 
or longer operative times. Arterial line hemodynamic monitoring 
should be considered in the aforementioned cases. Basic intravenous 
access considerations should account for limited patient access while 
the robot is docked; two intravenous lines of adequate bore should 
be placed and sufficient length afforded to tubing such that the lines 
can be accesses proximal to the anesthesia workstation. Just as with 
monitoring, intravenous access should be expanded accordingly to 
account for patient or surgical concerns.
Induction: Standard intravenous induction is feasible, adjusting 
anesthetic planning based on the patient’s medical condition. The 
endotracheal tube should be taped securely, appreciating that patient 
positioning may alter tube placement over time (unintended extubation 
or mainstem intubation), robotic instrumentation may dislodge a tube, 
and an obstructed view may delay recognition of a tube that has become 
dislodged [44]. Replacing an endotracheal tube would be challenging 
for robotic surgery patients based on positioning and the time delay 
associated with undocking. Post-induction, care should also be taken 
to balance the need for continued sedation against any hemodynamic 
instability that may result from the prolonged preparation time prior to 
surgical stimulus. Processed electroencephalographic monitoring such 
as BIS (Covidian, Inc, Mansfield, MA) or vasopressor agents may be 
required to bridge the time between induction and surgical incision. 
Immobility: Trocar placement carries with it the risk of injury 
to an organ or major vessel. Furthermore, once the robot is docked, 
surgical instruments are rigidly attached to the patient via trocar 
insertion sites. Based on these factors, it is imperative that patients be 
completely immobilized throughout the procedure until the robot is 
undocked. Non-depolarizing muscle relaxant drug, either by bolus or 
infusion, should be sufficient to achieve patient immobility [26]. At our 
institution, surgeons have noted that pelvic floor musculature becomes 
mobile with patient respirations as paralysis wanes, often prior to 
twitch monitor evidence indicating the need for drug re-dosing. 
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Consequently, deep paralysis, often to the exclusion of train-of-four 
twitches, is required for visualization during gynecologic or urologic 
robotic surgery. Secondarily, drug-induced paralysis may assist with 
mechanical ventilation for patients following pneumoperitoneum 
and steep trendelenberg positioning (see discussion below). Another 
safety measure that has been proposed to prevent accidently patient 
movement is to turn bed controls to the “off” position while the robot 
is docked. 
Pneumoperitoneum: After initial trocar placement, intra 
abdominal pressures are increased to 20 mm Hg with carbon dioxide 
(CO2) insufflation. After all ports are positioned, pressures are reduced 
to 12–15 mm Hg [27]. CO2 insufflation carries the risks for venous gas 
embolism, decreased venous return to the heart, vagal nerve activation 
of parasympathetics, and acute cardiovascular collapse. For prostate 
surgery, risk for venous gas embolism is greatest during the dissection 
of the dorsal venous complex [13,45]. Management of gas embolism 
involves supportive care while undocking the robot, positioning the 
patient in the left lateral decubitus position, and aspiration of gas via 
a multiport central venous catheter, if possible [19]. Hypercarbia is 
common; however, hypercarbia has never been reported as the cause 
of a clinically significant problem intraoperatively [19]. Subcutaneous 
emphesema, pneumomediastinum, hypothermia, and pneumothorax 
are all possibilities, although studies to investigate possible pathology 
should be guided by clinical suspicion rather than routine order sets. 
Physiologic changes, such as decreased pulmonary compliance and 
cardiac output occur with pneumoperitoneum and will be expanded 
upon in the discussion below. 
Positioning: For the majority of gynecologic and urologic surgeries 
that utilize robotic assistance, the positioning is modified lithotomy in 
stirrups with steep (30 degree) trendelenberg in order to utilize gravity 
to pull abdominal structures cephalad [1,41]. Arms and hands are 
heavily padded and tucked in a neutral position at the patient’s side, 
taking note of the functionality of monitoring and intravenous lines 
post-positioning. Egg crate foam padding or a padded beanbag is 
used to prevent sliding and the chest is bound in the form of an “X” 
[35]. Particular attention should be paid to padding shoulder braces 
to prevent injury with prolonged head-down positioning. Other 
possible strategies for positioning include: taping a gel pad to the bed 
to prevent sliding, or placing a Mayo stand over the patient’s head 
to prevent instrument-related facial injury [6,27]. At our institution, 
one patient developed alopecia as a result of prolonged pressure on 
the scalp following robotic gynecologic surgery that led to the local 
recommendation for intermittent head repositioning intraoperatively. 
Nerve injury can result from compression or stretching if 
improperly positioned and padded during robotic surgery. Injury to 
one or more nerves represents 16% of closed-claims complaints [38]. 
These injuries, when mild are reversible, but may be permanent if severe 
as a result of axonal denervation. Common nerve injuries to protect 
against include: brachial plexus, ulnar, and lateral femoral cutaneous 
nerves. Attention should be paid to the degree of limb extension, stirrup 
location, padding of bony prominences, and duration of immobility 
[19]. Prolonged, steep trendelenberg could result in plethoric facies 
and laryngeal edema as well [33]. 
Partial nephrectomy is performed with alternate positioning. 
Patients are placed in the lateral decubitus position with a kidney rest 
at the iliac crest. The lower hip is flexed, resulting in blood pooling in 
the lower extremities, decreased blood return and cardiac output, and 
distal arm neuropraxias and nerve compression injuries [33].
Physiologic change: Hemodynamic changes that occur with 
pneumoperitoneum include increased Systemic Vascular Resistance 
(SVR), Mean Arterial Pressures (MAP) and filling pressures as well 
as a 50% decrease of Cardiac Index (CI). The SVR and CI normalize 
after 10 minutes [1]. Central venous pressure and wedge pressures 
may increase. The addition of trendelenberg positioning may decrease 
cardiac output by 10–30% [1]. These changes, in addition to the risk for 
embolic events, put the patient at risk for hemodynamic collapse. In 
the event that intraoperative Advanced Cardiac Life Support (ACLS) 
measures are required, the robot must first be undocked and trocars 
removed prior to defibrillation. Critical delay to instituting life saving 
measures may occur if the surgical team is not adequately prepared to 
abort a robotic procedure in roughly 1 minute [1,19,26]. 
The risk of bleeding is greatest during port insertion near the 
inferior epigastrics and, for prostate surgery, during dissection of the 
dorsal venous complex. Robotic surgery typically yields less blood 
loss and consequently fewer transfusions than open procedures that 
do not have the benefit of pneumoperitoneum pressure gradients 
tamponading small veins and capillaries [19]. Urine output monitoring 
might not be available as an aid to the determination of volume status; 
for example, due to the open bladder in prostate surgery. In order to 
minimize the amount of urine that is produced into the surgical field, 
as well as to decrease edema of dependent parts, fluids are typically 
limited to 1-2 liters until critical portions of the operation requiring 
optimal visualization are complete [27]; afterwards, a clinically guided 
management strategy for crystalloid will suffice.
Minimizing ischemic time is an evolving topic for anesthesia 
providers during robot-assisted partial nephrectomy. Reducing 
ischemic time from hilar clamping limits renal damage as evidence by 
Glomerular Filtration Rate (GFR) measurements. Ischemic time greater 
than 28 minutes has been shown to reduce renal function for up to a 
year [46]. Substituting hilar clamping for deliberate hypotension prior 
to incision of the renal parenchema is an alternative that his gaining 
popularity. Hypotension may be induced with a combination of volatile 
anesthetic with nitroglycerine and esmolol infusions or boluses to 
maintain a Mean Arterial Pressure (MAP) of 60. Gill et al. report giving 
1-2L crystalloid bolus preoperatively and beginning a 20% mannitol 
infusion at 20 mL per hour 1 hour prior to inducing hypotension. They 
measured Mixed Venous Oxygen (MVO2) saturation throughout the 
hypotensive period and adjusted pressures to maintain MVO2 greater 
than 40 [32]. 
Pulmonary physiologic changes that occur with robotic surgery 
include decreased compliance from restrictive forces induced by 
chest padding as well as the cephalad displacement of the diaphragm 
from pneumoperitoneum and trendelenberg positioning. Functional 
residual capacity is decreased and peak airway pressures are increased 
[1,41]. Hypercarbia induced by pneumoperitoneum results in 
respiratory acidosis. Acidosis may be exacerbated by CO2 embolism 
or preexisting pulmonary disease [1]. Either pressure or volume-
controlled ventilation strategies are acceptable, but the ventilation 
strategy must account for peak pressures that are often increased by 
50% [35]. To compensate for high pressures, hypercapnia, and the 
desire to lower tidal volumes for improved surgical view, anesthesia 
providers should alter minute ventilation by titrating respiratory rate. 
Atelectasis that results in shunting of blood often occurs, resulting in 
hypoxia [33]. Peak End-Expiratory Pressures (PEEP) can improve gas 
exchange and should therefore be considered if peak pressures remain 
below safe limits.
Steep Tendelenbergpositioning leads to increases cerebral 
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blood flow and pressure, and decreased venous outflow; therefore, 
patients with preexisting intracranial or ocular pathology may be at 
increased risk that requires careful consideration [1,41]. Blood flow 
to intraabdominal organs such as intestines, kidneys and liver is 
decreased due to decreased flow to systemic and portal circulations that 
accompany pneumoperitoneum. 
Surgical injury: Intraoperative surgical risk has been reported at 
0.8-2% bleeding requiring transfusion, 1.3% urinary leak, 0.5% wound 
infection, 0.2% bowel injury, and 0.2% femoral nerve palsy [27]. Other 
concerns should include: port-site hernia, anastamotic leak, and other 
peripheral nerve injuries [1]. The robot light source produces more 
heat than typical laparoscopy and therefore demands greater vigilance 
to prevent burns or fire [47].
Robot malfunction: Robotic malfunction is a concern. 2.6% failure 
rates have been reported due to joint, camera or arm failure, power 
errors, and monocular power loss or software incompatibility. One 
institution reported a non-recoverable robot malfunction of critical 
equipment of 0.4% [19]. Checklists can be instituted to further prevent 
equipment malfunction [45].
Emergence: 
to put the patient at risk for airway edema and failed extubation 
[26]. Several reviews have suggested conducting an airway cuff leak 
test prior to extubation as an indicator of risk for post-extubation 
stridor [19,26,44]. Patients who do not meet strict extubation criteria 
should remain intubated in the Post-Anesthesia Care Unit (PACU) 
until criteria are met. Often, allowing several hours for excretion of 
anesthetics and redistribution of fluids permits a safe extubation in the 
PACU. 
Postoperative Management
Airway complications such as stridor, laryngeal edema, 
obstruction, and tracheal deviation result in postoperative respiratory 
distress in roughly 0.7% of robotic surgeries, requiring postoperative 
re-intubation [30,44,48]. Postoperative ileus leading to abdominal 
distension and nausea can occur and should be monitored, advancing 
diet beyond clears when clinically indicated [35]. Pain management is 
often accomplished with intravenous, multimodal therapy including 
narcotic, non-steroidal, neuropathic and acetaminophen analgesics 
[15,49]. Epidurals are typically not required for robotic incision pain 
[35]. 
Referred shoulder pain as a result of pneumoperitoneum’s effect on 
the  phrenic  nerve, and a variety of neuropathies may present in the 
postoperative period [30,38]. Postoperatively, kidney function should 
be monitored as pneumoperitoneum may inhibit urinary excretion, 
decrease creatinine clearance, glomerular filtration rate and renal blood 
flow for up to 3 days postoperatively [30]. If urine output is less than 
0.5 mg per mL per hour, a bolus of crystalloid should be considered. 
Encouraging early ambulation mitigates the risk of postoperative deep 
vein thrombosis [35].
Future Considerations 
Comparable cancer-free outcomes with improved functional 
outcomes will continue the growth of robotic surgery for gynecologic 
and urologic surgery in spite of cost concerns. Invariably, competition 
for the da Vinci Surgical System, such as Titan Medical Inc’s Amadeus 
System (Toronto, ON, CA), and The University of Santa Cruz’s Raven 
Project, will enter the robotic surgery space, bringing down costs 
and driving quality and innovation. One area in need of innovation 
is patient positioning where most institutions currently rely on self-
created padding held together with tape to ensure safety with extreme 
positioning [20]. Practitioner proficiency and competency will need 
to be ensured by standardization of practice and credentialing on a 
national level [18,20]. The future of minimally invasive surgery with 
robotic technology holds great potential. Laproendoscopic Single 
Site Surgery (LESS) with robot-assistance [34], and Natural Orifice 
Transluminal Endoscopic Surgery (NOTES) are in development [2] 
as are robotics with haptic sensation. In vivo mini-robots that deploy 
intracorporeally for imaging and retracting are in development as well. 
Anesthesiologists would do well to prepare themselves for the robotic 
surgery revolution.
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